Mifepristone in abortion care

Seminars in Reproductive Medicine

Volumn 23, Issue 1, 2005, Pages 82-91

  Schreiber, Courtney ^a   Creinin, Mitchell ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Medical abortion; Mifepristone; Misoprostol

Indexed keywords

ABORTIVE AGENT; GEMEPROST; MIFEPRISTONE; MISOPROSTOL; PROGESTERONE; PROGESTERONE RECEPTOR; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E1;

ABORTION; COUNSELING; DIARRHEA; DRUG EFFICACY; DRUG HALF LIFE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GESTATION PERIOD; HUMAN; LABOR INDUCTION; OUTPATIENT; PATIENT CARE; PREGNANCY; PRESCRIPTION; REVIEW; SECOND TRIMESTER PREGNANCY; TERATOGENICITY; UTERUS; VACUUM ASPIRATION;

ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; FEMALE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, ANCIENT; HUMANS; MIFEPRISTONE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND;

EID: 14744297879     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-864036     Document Type: Review

References (78)

1. Pincus G. The Control of Fertility. New York: Academic Press; 1965:128-138
2. Peyron R, Aubény E, Targosz V, et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 1993;328:1509-1513
3. Aubény E, Peyron R, Turpin CL, et al. Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone (RU486) and increasing doses of misoprostol. Int J Fertil Menopausal Stud 1995;40(suppl 2):85-91
4. Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998;338:1241-1247
5. Aubeny E. A two-stage increase in the dose of misoprostol improves the efficacy of medical abortion with mifepristone and prostaglandins (letter). Eur J Contracept Reprod Health Care 2001;6:54-55
6. Schaff EA, Eisinger SH, Stadalius LS, et al. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 1999;59:1-6
7. Ngai SW, Yeung KC, Lao T, Ho PC. Oral misoprostol versus mifepristone for cervical dilatation before vacuum aspiration in first trimester nulliparous pregnancies: a double blind prospective randomized study. BJOG 1996;103:1120-1123
8. Carbonne B, Brennand JE, Maria B, Carbrol D, Calder AA. Effects of gemeprost and mifepristone on the mechanical properties of the cervix prior to first trimester termination of pregnancy. BJOG 1995;102:553-558
9. Ashok PW, Flett GM, Templeton A. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study. Am J Obstet Gynecol 2000;183:998-1002
10. Pohls UG, Steck T, Dietl J. Fetal complications after failed pregnancy termination in the first trimester. Z Geburtshilfe Neonatol 2000;204:153-157
11. Autry AM, Hayes EC, Jacobson GF, Kirby RS. A comparison of medical induction and dilatation and evacuation for second trimester abortion. Am J Obstet Gynecol 2002;187:393-397
12. Royal College of Obstetricians and Gynecologists. The care of women requesting induced abortion. London: RCOG; 2000
13. Grimes DA, Cates W. Complications from legally-induced abortion: a review. Obstet Gynecol Surv 1979;34:171-191
14. Rodger MT, Baird DT. Pre-treatment with mifepristone (RU-486) reduces interval between prostaglandin administration and expulsion in second trimester abortion. BJOG 1990;97:41-45
15. Webster D, Gillian PC, Templeton A. A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol. BJOG 1996;103:706-709
16. Creinin MD. Medical abortion regimens: Historical context and overview. Am J Obstet Gynecol 2000;183:S3-S9
17. McFarlane DR. Induced abortion: a historical overview. Am J Gynecol Health 1993;7:77-83
18. Heikinheimo O, Tevilin M, Shoupe D, Croxatto H, Lahteenmaki P. Quantitation of RU 486 in human plasma by HPLC and RIA after chromatography. Contraception 1993;48:133-149
19. Mahajan DK, London SN. Mifepristone (RU486): a review. Fertil Steril 1997;86:967-976
20. Hermann WL, Schlindler AM, Wyss R, Bischoff P. Effects of antiprogesterone RU 486 in early pregnancy and during the menstrual cycle. In: Beaulieu EE, Siegel S, eds. The antiprogestin steroid RU 486 and human fertility control. New York: Plenum; 1985:259-262
21. Swahn ML, Bygdeman M. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. BJOG 1988;95:126-134
22. Creinin MD, Fox MC, Teal S, Chen A, Schaff EA, Meyn LA. A randomized Comparison of Misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. Obstet Gynecol 2004;103:851-859
23. Birgerson L, Odlind V. Early pregnancy termination with antiprogestins: a comparative clinical study of mifepristone given in two dose regimens and Epostane. Fertil Steril 1987;48:565-570
24. Kovacs L, Sas M, Resch BA, et al. Termination of very early pregnancy by RU 486, an antiprogestational compound. Contraception 1984;29:399-410
25. Birgerson L. Clinical effects of RU 486 administered for seven days in early pregnancy. In: Baulieu EE, Siegel S, eds. The Antiprogestin Steroid RU 486 and Human Fertility Control, New York: Plenum; 1985:235-241
26. Swahn ML, Cekan S, Wang G, Lujndstrom V, Bygdeman M. Pharmacokinetic and clinical studies of RU 486 for fertility regulation. In: Baulieu EE, Siegel S, eds. The Antiprogestin Steroid RU 486 and Human Fertility Control, New York: Plenum; 1985:249-258
27. Bygdeman M, Swahn ML. Progesterone receptor blockage. Effect on uterine contractility and early pregnancy. Contraception 1985;32:45-51
28. Shoupe D, Mishell DR Jr, Brenner PF, Spitz IM. Pregnancy termination with a high and medium dosage regimen of RU486. Contraception 1986;33:455-461
29. Center for Reproductive Law and Policy. Available at: http://www.crlp.org
30. Norman JE, Thong KJ, Baird DT. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet 1991;338:1233-1236
31. Creinin MD, Vittinghoff E. Methotrexate and misoprostol vs. misoprostol alone for early abortion: a randomized controlled trial. JAMA 1994;272:1190-1195
32. Bugalho A, Faundes A, Jamisse L, Usfa M, Maria E, Bique C. Evaluation of the effectiveness of misoprostol to induce first trimester abortion. Contraception 1996;53:237-242
33. Koopersmith TB, Mishell DR. The use of misoprostol for termination of early pregnancy. Contraception 1996;53: 237-242
34. Carbonell JLL, Varela L, Velazco A, Fernandez C. The use of misoprostol for termination of early pregnancy. Contraception 1997;55:165-168
35. Jain JK, Mishell DR, Mekstroth K, Lacarra M. The use of vaginal misoprostol for termination of pregnancies <56 days. Paper presented at the American Public Health Association 126th Annual Meeting; November 15-18; 1998; Washington, DC
36. El-Rafaey H, Rajasekar D, Abdalla M, et al. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995;332:983-987
37. Wiebe E, Dunn S, Guilbert E, et al. Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol. Obstet Gynecol 2002;99:813-819
38. Jones RK, Henshaw SK. Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden. Perspect Sex Reprod Health 2002;34:154-161
39. World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 1993;307:532-537
40. McKinley C, Thong KJ, Baird DT. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod 1993;8:1502-1505
41. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. BJOG 2000;107:524-530
42. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. BJOG 2000;107:524-530
43. Ashok P, Penney G, Flett G, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 1998;13:2962-2965
44. Schaff EA, Fielding SL, Eisinger SH, et al. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 2000;61:41-46
45. Tang OS, Ho PC. Pilot study on the use of sublingual misoprostol for medical abortion. Contraception 2001;64:315-317
46. Tang OS, Xu J, Cheng L, et al. Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks gestation. Hum Reprod 2002;17:1738-1740
47. Schaff EA, Fielding SL, Westhoff C. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. Contraception 2001;64:81-85
48. El-Rafaey H. Early induction of abortion by a combination of oral mifepristone and misoprostol administered by the vaginal route. Contraception 1994;49:111-114
49. Bartley J, Brown A, Elton R, Baird DT. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost of misoprostol for induction of abortion up to 63 days gestation. Hum Reprod 2001;16:2098-2102
50. von Hertzen H, Honkanen H, Piaggio G, Bartfai ER, et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion I: Efficacy. BJOG 2003;110:808-818
51. Schaff EA, Stadalius LS, Eisinger SH, Franks P. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract 1997;44:353-360
52. Schaff EA, Fielding SL, Westhoff C, et al. Randomized trial of vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion (< 56 days gestation). JAMA 2000;284:1948-1953
53. Pymar HC, Creinin MD, Schwartz JL. Mifepristone followed on the same day by vaginal misoprostol for early abortion. Contraception 2001;64:87-92
54. Fox MC, Creinin MD, Harwood B. Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestation. Contraception 2002;66:225-229
55. Harwood B, Meckstroth KR, Mishell DR, Jain JK. Serum beta-human chorionic gonadotropin levels and endometrial thickness after medical abortion. Contraception 2001;63:255-256
56. Thong KJ, Baird DT. Induction of abortion with mifepristone and misoprostol in early pregnancy. Br J Obstet Gynaecol 1992;99:1004-1007
57. Davis A, Westhoff C, De Nonno L. Bleeding patterns after early abortion with mifepristone and misoprostol or manual vacuum aspiration. Journal of the American Medical Women's Association 2000;55:141-144
58. Tang OS, Gao PP, Cheng L, et al. A randomized double-blind placebo-controlled study to assess the effect of OC pills on the outcome of medical abortion with mifepristone and misoprostol. Hum Reprod 1999;14:722-725
59. Tang OS, Xu J, Cheng L, et al. The effect of contraceptive pills on the measured blood loss in medical termination of pregnancy by mifepristone and misoprostol a randomized placebo controlled trial. Hum Reprod 2002;17:99-102
60. Breitbart V, Callaway D. The Counseling Component of Medical Abortion. Journal of the American Medical Women's Association 2000;55:164-166
61. Kletzky OA, Marrs RP, Howard WF, McCormick W, Mishell DR Jr. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion. Am J Obstet Gynecol 1979;135:731-736
62. Lahteenmaki P. The disappearance of hCG and return of pituitary function after abortion. Clin Endocrinol 1978;9:101-112
63. Lahteenmaki P, Luukkainen T. Return of ovarian function after abortion. Clin Endocrinol 1978;8:123-132
64. Cameron IT, Baird DT. The return to ovulation following early abortion: a comparison between vacuum aspiration and prostaglandin. Acta Endocrinol (Copenh) 1988;118:161-167
65. Donnet ML, Howie M, Cooper W, Lewis M. Return of ovarian function following spontaneous abortion. Clin Endocrinol 1990;33:13-20
66. Stewart FH, Wells ES, Flinn SK, Weitz TA. Early Medical Abortion: Issues for Practice. San Francisco, CA: UCSF Center for Reproductive Health Research and Policy; 2001
67. Ashok PW, Gillian F, Templeton A. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study. Am J Obstet Gynecol 2000;183:998-1002
68. Gouk EV, Lincoln K, Khair A, Haslock J, Knight J, Cruickshank DJ. Medical termination of pregnancy at 63 to 83 days gestation. BJOG 1999;106:535-539
69. Ashok PW, Gillian F, Templeton A. Termination of pregnancy at 9-13 weeks' amenorrhea with mifepristone and misoprostol. Lancet 1998;352:542-543
70. Jain JK, Mishell DR. A comparison of intravaginally misoprostol with prostaglandin E2 for termination of second trimester pregnancy. N Engl J Med 1994;331:290-293
71. Ho PC, Yu N, Hung E, Tang OS. Mifepristone: contraceptive and non-contraceptive uses. Curr Opin Obstet Gynecol 2002;14:325-330
72. Ngai SW, Tang OS, Ho CP. Randomized comparison of vaginal (200 μg every 3 h) and oral (400 μg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy. Hum Reprod 2000;15:2205-2208
73. El-Rafey H, Hinshaw K, Templeton A. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486). Hum Reprod 1993;8:1744-1746
74. Ho PC, Tsang SSK, Ma HK. Reducing the induction to abortion interval in termination of second trimester pregnancies: a comparison of mifepristone with laminaria tent. BJOG 1995;102:648-651
75. Goujard J. Mifépristone, risque téraogenes. L'interruption de grossesse depuis in loi veil. Flammarion 1992;55-57
76. Hamoda H, Ashok G, Templeton A. Medical abortion at 64 to 91 days of gestation: a review of 483 consecutive cases. Am J Obstet Gynecol 2002;188:1315-1319
77. Fonseca W, Alencar AJC, Mota FSB, Coelho HLL. Misoprostol and congenital malformations. Lancet 1991;338:56
78. Pastuszak A, Schuler L, Speck-Martin CE, et al. Use of misoprostol during pregnancy and Mobius' syndrome in infants. N Engl J Med 1998;338:1881-1885